The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AEROVATE THERAPEUTICS INC | COMM | 008064107 | 29,871,288 | 2,201,274 | SH | SOLE | 2,201,274 | 0 | 0 | |||
AN2 Therapeutics, Inc. | COMM | 037326105 | 43,065,600 | 2,678,209 | SH | SOLE | 2,678,209 | 0 | 0 | |||
C4 THERAPEUTICS, INC. | COMM | 12529R107 | 2,374,427 | 1,276,574 | SH | SOLE | 1,276,574 | 0 | 0 | |||
CABALETTA BIO, INC | COMM | 12674W109 | 7,409,020 | 486,795 | SH | SOLE | 486,795 | 0 | 0 | |||
CENTESSA PHARMACEUTICALS PLC | COMM | 152309100 | 13,204,079 | 2,040,816 | SH | SOLE | 2,040,816 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COMM | 19240Q201 | 54,902,659 | 5,631,042 | SH | SOLE | 5,631,042 | 0 | 0 | |||
COMPASS PATHWAYS PLC | ADRS | 20451W101 | 28,549,200 | 3,858,000 | SH | SOLE | 3,858,000 | 0 | 0 | |||
DYNE THERAPEUTICS, INC | COMM | 26818M108 | 14,785,344 | 1,650,150 | SH | SOLE | 1,650,150 | 0 | 0 | |||
ENTRADA THERAPEUTICS INC | COMM | 29384C108 | 9,242,289 | 584,955 | SH | SOLE | 584,955 | 0 | 0 | |||
GERON CORP | COMM | 374163103 | 49,556,779 | 23,375,839 | SH | SOLE | 23,375,839 | 0 | 0 | |||
GRACELL BIOTECHNOLOGIES INC. | ADRS | 38406L103 | 8,752,000 | 3,038,889 | SH | SOLE | 3,038,889 | 0 | 0 | |||
Icosavax, Inc. | COMM | 45114M109 | 28,703,706 | 3,703,704 | SH | SOLE | 3,703,704 | 0 | 0 | |||
IMMUNOVANT, INC | COMM | 45258J102 | 12,855,006 | 334,853 | SH | SOLE | 334,853 | 0 | 0 | |||
INHIBRX,INC | COMM | 45720L107 | 32,119,601 | 1,750,387 | SH | SOLE | 1,750,387 | 0 | 0 | |||
KALVISTA PHARMACEUTICALS, INC | COMM | 483497103 | 32,698,617 | 3,395,495 | SH | SOLE | 3,395,495 | 0 | 0 | |||
KURA ONCOLOGY INC | COMM | 50127T109 | 12,983,615 | 1,423,642 | SH | SOLE | 1,423,642 | 0 | 0 | |||
MADRIGAL PHARMACEUTICALS INC | COMM | 558868105 | 26,275,079 | 179,917 | SH | SOLE | 179,917 | 0 | 0 | |||
MERUS N.V. | COMM | N5749R100 | 7,074,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
SAVARA INC. | COMM | 805111101 | 37,800,000 | 10,000,000 | SH | SOLE | 10,000,000 | 0 | 0 | |||
SILENCE THERAPEUTICS PLC | ADRS | 82686Q101 | 20,669,873 | 2,104,875 | SH | SOLE | 2,104,875 | 0 | 0 | |||
TARSUS PHARMACEUTICALS, INC. | COMM | 87650L103 | 20,308,569 | 1,142,857 | SH | SOLE | 1,142,857 | 0 | 0 | |||
TAYSHA GENE THERAPIES, INC. | COMM | 877619106 | 35,111,111 | 11,111,111 | SH | SOLE | 11,111,111 | 0 | 0 | |||
TYRA BIOSCIENCES INC | COMM | 90240B106 | 27,389,948 | 1,989,103 | SH | SOLE | 1,989,103 | 0 | 0 | |||
VENTYX BIOSCIENCES, INC | COMM | 92332V107 | 28,330,095 | 815,724 | SH | SOLE | 815,724 | 0 | 0 | |||
STRUCTURE THERAPEUTICS INC | ADRS | 86366E106 | 75,768,504 | 1,502,747 | SH | SOLE | 1,502,747 | 0 | 0 | |||
RAYZEBIO, INC. | COMM | 75525N107 | 19,311,958 | 869,908 | SH | SOLE | 869,908 | 0 | 0 |